Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02401217 · ClinicalTrials.gov registry record · NA

Tolerance of Healthy Infants Fed Infant Formulas

A NA study of Gastrointestinal Tolerance, sponsored by Abbott Nutrition.

Completed
Registry status
NA
Development phase
126
Enrollment target
6
Study locations

NCT02401217 is a NA study of Gastrointestinal Tolerance that has completed, run by Abbott Nutrition. The registered enrollment target is 126 participants, below the 172-participant average among 3 other Gastrointestinal Tolerance trials with a reported enrollment target (27% lower). The trial reports 6 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02401217, a NA study of Gastrointestinal Tolerance, has completed, sponsored by Abbott Nutrition.

COMPLETED
Registry status
NA
Development phase
126 participants
Enrollment target
6
Study locations

Study Summary

The primary objective of this study is to assess the comparative gastrointestinal tolerance of normal term infants to two experimental milk-based powdered formulas compared with a standard milk-based powdered formula.

Conditions Studied

Interventions

  • OTHER Phase 1- Arm 1 Infant Formula
  • OTHER Phase 2- Arm 2 Infant Formula
  • OTHER Phase 2- Arm 3 Infant Formula

Study Locations (6)

Ohio

  • Institute of Clinical Research, LLC - Mayfield Heights
  • The Cleveland Pediatric Research Center, LLC - Middleburg Heights

Arizona

  • W.O.M.B Watching Over Mothers and Babies - Tucson

Florida

  • SCORE Physician Alliance LLC - St. Petersburg

North Carolina

  • White Oak Family Physicians DBA/Asheboro Research Associates - Asheboro

Utah

  • Tanner Memorial Clinic - Layton

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2015-04
Est. Completion 2015-09
Phase NA

Sponsor

Abbott Nutrition

89 total trials

What the Registry Record Tells You About NCT02401217

The ClinicalTrials.gov registry entry for NCT02401217 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 172-participant average among 3 other Gastrointestinal Tolerance trials with a reported enrollment target (27% lower). The listed sponsor is Abbott Nutrition, which has 89 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gastrointestinal Tolerance appearing as the primary indexed condition, and to 3 interventions - of which Phase 1- Arm 1 Infant Formula is the first listed.

NCT02401217 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Ohio, Arizona, Florida.

Frequently Asked Questions

What is clinical trial NCT02401217 about?

NCT02401217 is a clinical study titled "Tolerance of Healthy Infants Fed Infant Formulas". The primary objective of this study is to assess the comparative gastrointestinal tolerance of normal term infants to two experimental milk-based powdered formulas compared with a standard milk-based powdered formula.

What is the current status of trial NCT02401217?

This trial is currently completed. It is a NA study. The enrollment target is 126 participants. The study started on 2015-04. Estimated completion is 2015-09.

What conditions does trial NCT02401217 study?

This clinical trial studies the following conditions: Gastrointestinal Tolerance.

What interventions are being tested in trial NCT02401217?

The interventions under investigation include: Phase 1- Arm 1 Infant Formula (OTHER), Phase 2- Arm 2 Infant Formula (OTHER), Phase 2- Arm 3 Infant Formula (OTHER).

Who is sponsoring clinical trial NCT02401217?

This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02401217 being conducted?

This trial has 6 study locations across Arizona, Florida, North Carolina, Ohio, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastrointestinal Tolerance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.